Supply Medicines Human Use Whose Active Ingredients Are Aztreonam, Emricitabine, Rilpivirine, Dysoproxil Fumarate, Tenofovir Alaphenamide, Tenofovir Alafenamide Fumarate, Idelalisib, Ledipasvir, Elvitegravir, Cobicistat, Velpatatasvir, Sofosbuvir, Voxila Prevevir Sedesivir, Sacituzumab And Lenacapavir, Bound For The Centers In The Field Of Valencian Public Health

Direccion General de Gestion Economica, Contratacion e Infraestructuras de la Conselleria de Sanidad Spain has Released a tender for Supply Medicines Human Use Whose Active Ingredients Are Aztreonam, Emricitabine, Rilpivirine, Dysoproxil Fumarate, Tenofovir Alaphenamide, Tenofovir Alafenamide Fumarate, Idelalisib, Ledipasvir, Elvitegravir, Cobicistat, Velpatatasvir, Sofosbuvir, Voxila Prevevir Sedesivir, Sacituzumab And Lenacapavir, Bound For The Centers In The Field Of Valencian Public Health in Pharmaceuticals. The tender was released on Feb 10, 2025.

Country - Spain

Summary - Supply Medicines Human Use Whose Active Ingredients Are Aztreonam, Emricitabine, Rilpivirine, Dysoproxil Fumarate, Tenofovir Alaphenamide, Tenofovir Alafenamide Fumarate, Idelalisib, Ledipasvir, Elvitegravir, Cobicistat, Velpatatasvir, Sofosbuvir, Voxila Prevevir Sedesivir, Sacituzumab And Lenacapavir, Bound For The Centers In The Field Of Valencian Public Health

Deadline - Feb 25, 2025

GT reference number - 103037288

Product classification - Pharmaceutical products